About Gamifant

The safety and effectiveness of Gamifant was studied in a clinical trial for the treatment of primary HLH. The clinical trial looked at:

  • How effective Gamifant was for patients in the clinical trial with primary HLH who had received conventional therapy. These patients either hadn’t responded to or had bad side effects from conventional primary HLH therapy, or their disease came back
  • How safe Gamifant was for these patients
papers and notebooks

How may Gamifant help?

Results from the Gamifant clinical trial showed:


63% of patients had improvements in the signs and symptoms of primary HLH

drop with cross inside of it

70% of patients with primary HLH proceeded to transplant

talk bubble
Talk to your doctor to find out if Gamifant may be right for you or your loved one.